These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31407859)

  • 41. Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.
    Deutsch GK; Hagerman KA; Sampson J; Dent G; Dekdebrun J; Parker DM; Thornton CA; Heatwole CR; Subramony SH; Mankodi AK; Ashizawa T; Statland JM; Arnold WD; Moxley RT; Day JW;
    Muscle Nerve; 2022 May; 65(5):560-567. PubMed ID: 35179228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.
    Okkersen K; Jimenez-Moreno C; Wenninger S; Daidj F; Glennon J; Cumming S; Littleford R; Monckton DG; Lochmüller H; Catt M; Faber CG; Hapca A; Donnan PT; Gorman G; Bassez G; Schoser B; Knoop H; Treweek S; van Engelen BGM;
    Lancet Neurol; 2018 Aug; 17(8):671-680. PubMed ID: 29934199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.
    Peric S; Brajkovic L; Belanovic B; Ilic V; Salak-Djokic B; Basta I; Rakocevic Stojanovic V
    J Neurol Sci; 2017 Jul; 378():187-192. PubMed ID: 28566162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1.
    Raymond K; Levasseur M; Mathieu J; Gagnon C
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1629-1639. PubMed ID: 30831092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive function in myotonic dystrophy: a follow-up study.
    Tuikka RA; Laaksonen RK; Somer HV
    Eur Neurol; 1993; 33(6):436-41. PubMed ID: 8307065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1).
    Nicoletti TF; Rossi S; Vita MG; Perna A; Guerrera G; Lino F; Iacovelli C; Di Natale D; Modoni A; Battistini L; Silvestri G
    J Neurol; 2022 Sep; 269(9):5085-5092. PubMed ID: 35575811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification.
    De Antonio M; Dogan C; Hamroun D; Mati M; Zerrouki S; Eymard B; Katsahian S; Bassez G;
    Rev Neurol (Paris); 2016 Oct; 172(10):572-580. PubMed ID: 27665240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognition and event-related potentials in adult-onset non-demented myotonic dystrophy type 1.
    Tanaka H; Arai M; Harada M; Hozumi A; Hirata K
    Clin Neurophysiol; 2012 Feb; 123(2):261-9. PubMed ID: 21741303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive assessment in patients with myotonic dystrophy type 2.
    Peric S; Gunjic I; Delic N; Stojiljkovic Tamas O; Salak-Djokic B; Pesovic J; Petrovic Djordjevic I; Ivanovic V; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
    Neuromuscul Disord; 2022 Sep; 32(9):743-748. PubMed ID: 35879188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
    Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
    J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facial memory deficits in myotonic dystrophy type 1.
    Kleberg JL; Lindberg C; Winblad S
    Acta Neurol Scand; 2014 Nov; 130(5):312-8. PubMed ID: 24527956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive phenotype of childhood myotonic dystrophy type 1: A multicenter pooled analysis.
    Sweere DJJ; Moelands SVL; Klinkenberg S; Leenen L; Hendriksen JGM; Braakman HMH
    Muscle Nerve; 2023 Jul; 68(1):57-64. PubMed ID: 37129457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
    Weber YG; Roebling R; Kassubek J; Hoffmann S; Rosenbohm A; Wolf M; Steinbach P; Jurkat-Rott K; Walter H; Reske SN; Lehmann-Horn F; Mottaghy FM; Lerche H
    Neurology; 2010 Apr; 74(14):1108-17. PubMed ID: 20220122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body composition and clinical outcome measures in patients with myotonic dystrophy type 1.
    Sedehizadeh S; Brook JD; Maddison P
    Neuromuscul Disord; 2017 Mar; 27(3):286-289. PubMed ID: 28082208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy.
    van As D; Okkersen K; Bassez G; Schoser B; Lochmüller H; Glennon JC; Knoop H; van Engelen BGM; 't Hoen PAC;
    J Neuromuscul Dis; 2021; 8(6):1031-1046. PubMed ID: 34250945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.
    Roussel MP; Fiset MM; Gauthier L; Lavoie C; McNicoll É; Pouliot L; Gagnon C; Duchesne E
    J Neurol; 2021 Nov; 268(11):4221-4237. PubMed ID: 33907889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Childhood-onset form of myotonic dystrophy type 1 and autism spectrum disorder: Is there comorbidity?
    Angeard N; Huerta E; Jacquette A; Cohen D; Xavier J; Gargiulo M; Servais L; Eymard B; Héron D
    Neuromuscul Disord; 2018 Mar; 28(3):216-221. PubMed ID: 29361396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five-year study of quality of life in myotonic dystrophy.
    Peric S; Vujnic M; Dobricic V; Marjanovic A; Basta I; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
    Acta Neurol Scand; 2016 Nov; 134(5):346-351. PubMed ID: 27696366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of EEG-based functional brain networks in myotonic dystrophy type 1.
    Biere J; Okkersen K; van Alfen N; Kessels RPC; Gouw AA; van Dorst M; van Engelen B; Stam CJ; Raaphorst J;
    Clin Neurophysiol; 2020 Aug; 131(8):1886-1895. PubMed ID: 32590320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.